Display Settings:

Format

Send to:

Choose Destination
    Biomaterials. 2008 Nov;29(31):4149-56. Epub 2008 Aug 3.

    In vitro and in vivo suppression of cellular activity by guanidinoethyl disulfide released from hydrogel microspheres composed of partially oxidized hyaluronan and gelatin.

    Source

    Department of Biomedical Engineering, T18-030 Health Sciences Center, State University of New York-Stony Brook, Stony Brook, NY 11794-8181, USA.

    Abstract

    This paper describes the preparation of oxidized hyaluronan crosslinked gelatin microspheres for drug delivery. Microspheres were prepared by a modified water-in-oil-emulsion crosslinking method, where three-dimensional crosslinked hydrogel microspheres formed in the absence of any extraneous crosslinker. SEM analyses of the microspheres showed rough surfaces in their dried state with an average diameter of 90 microm. Lyophilization of fully swollen microspheres revealed a highly porous structure. Guanidinoethyl disulfide (GED) was used as a model drug for incorporation into the microspheres; encapsulation of GED was confirmed by HPLC. There was an inverse correlation between the diameters of the microspheres with their GED loading. Macrophage was used as a model cell to evaluate the in vitro efficacy of GED release from the microspheres. The in vivo efficacy of the microspheres was further validated in a mouse full-thickness transcutaneous dermal wound model through suppression of cell infiltration.

    PMID:
    18678403
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2577076
    Free PMC Article

    Images from this publication.See all images (9) Free text

    Fig. 2
    Fig. 4
    Fig. 6
    Fig. 8
    Fig. 3
    Fig. 5
    Fig. 7
    Fig. 9

      Supplemental Content

      Icon for Elsevier Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk